Inhibitory Activity of Compounds Isolated from Ligustrum robustum (Roxb.) Against HepG2 Liver Cancer Cells: Isocubein and 4‐(2‐Acetoxyethyl)phenol as Potential Candidates

Author:

Nong Thi Anh Thu1,Le Thi Thanh Huong2,Vu Van Tuan3,Nguyen Mai Quynh4ORCID,Can Dinh Quang Hung2,Dong Thi Hoang Yen1,Nguyen Thi Phuong Thao1,Hoang Van Hung4,Nguyen Phu Hung4

Affiliation:

1. Thai Nguyen University of Medicine and Pharmacy Thai Nguyen University Thai Nguyen Vietnam

2. Thai Nguyen University of Sciences Thai Nguyen University Thai Nguyen Vietnam

3. Faculty of Pharmacy Phenikaa University Hanoi Vietnam

4. Center for Interdisciplinary Science and Education Thai Nguyen University Thai Nguyen Vietnam

Abstract

AbstractMany herbal species in the genus Ligustrum have been shown to contain compounds with anti‐cancer biological activity. This study aimed to isolate some compounds from the leaves of Ligustrum robustum (Roxb.) Blume (L. robustum) and evaluate their effects against liver cancer cells. As a result, seven previously reported compounds (17) were isolated, including four lignans (14) and three phenolic derivatives (57). The structures of these compounds were determined using spectroscopic methods and comparison with reported data. All isolates were assessed for their inhibitory effects on HepG2 liver cancer cells. Screening results revealed that two compounds, isocubein (3) and 4‐(2‐acetoxyethyl)phenol (7), exhibited strong inhibitory activity against cell proliferation, with IC50 values of 3.1±0.9 and 4.5±14 μM, respectively. Further analyses demonstrated that both compounds could suppress the formation and development of 3D tumorspheres in terms of quantity and size. Additionally, isocubein (3) and 4‐(2‐acetoxyethyl)phenol (7) exhibited the ability to inhibit the migration of HepG2 cells. This study represents the first report on the inhibitory activity against HepG2 liver cancer cells of extracts and isolated compounds from L. robustum, providing valuable information for future research aiming to develop products for liver cancer treatment.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3